Josep Manyé

Dr. Josep Manyé

1. Germans Trias i Pujol Institute (IGTP), Madrid, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RSRoger Suau
Roger Suau
AGAnna Garcia
Anna Garcia
CECarla Bernal Espinoza
Carla Bernal Espinoza
MLMariona Llaves
Mariona Llaves
KSKatharina Schiering
Katharina Schiering
JMJosep Manyé
Josep Manyé
The lack of knowledge regarding the pathogenesis of IBD is a challenge for the development of more effective and safer therapies. Although in vivo preclinical approaches are critical for drug testing, none of the existing models accurately reproduce human IBD. Factors that influence the intra-individual response to drugs have barely been described. With this in mind, our aim was to compare the anti-inflammatory efficacy of a new molecule (MTADV) to that of corticosteroids in TNBS and DSS-induced colitis mice of both sexes in order to clarify further the response mechanism involved and the variability between sexes. The drugs were administered preventively and therapeutically, and real-time bioluminescence was performed for the in vivo time-course colitis monitoring. Morphometric data were also collected, and colonic cytokines and acute plasma phase proteins were analyzed by qRT-PCR and ELISA, respectively—bioluminescence images correlated with inflammatory markers. In the TNBS model, dexamethasone worked better in females, while MTADV improved inflammation in males. In DSS-colitis, both therapies worked similarly. Based on the molecular profiles, interaction networks were constructed to pinpoint the drivers of therapeutic response that were highly dependent on the sex. In conclusion, our results suggest the importance of considering sex in IBD preclinical drug screening.

19 January 2026 in medRxiv
Verified
Preprint
Open access
PDF file
RSRoger Suau
Roger Suau
MLMireia Lopez-Siles
Mireia Lopez-Siles
MCMargalida Cabrer
Margalida Cabrer
MRMarina Rovira
Marina Rovira
LCLaura Clua
Laura Clua
JMJosep Manyé
Josep Manyé
Background: Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by high post-operative recurrence (POR) rates, reaching up to 90% within one year. Current clinical and endoscopic predictors show limited accuracy. Objective: This study aimed to identify molecular mechanisms associated with POR at the time of surgery through integrated transcriptomic and bacteriomic analyses of ileal tissue. Design: Ileal samples were obtained during surgery from 20 patients with CD and 10 inflammatory bowel disease–free controls, with an independent validation cohort of 49 patients with CD. POR was evaluated every six months using ileocolonoscopy and defined by Rutgeerts score. Host gene expression and tissue-associated microbiome profiles were integrated using correlation and pathway enrichment analyses to uncover host–microbe interactions linked to POR. Results: In the inflamed mucosa of patients who developed endoscopic POR, we identified a novel immune interaction involving the Porphyromonadaceae family, mainly Parabacteroides gordonii , which was slightly depleted. This depletion was associated with downregulation of epithelial barrier and tissue repair genes, including TFF1 and LSR , findings confirmed in the validation cohort. Porphyromonadaceae abundance positively correlated with short-chain fatty acid levels, particularly propionate. Additionally, omics integration revealed an association between Xanthomonadaceae and increased expression of ITGAM , a gene involved in neutrophil activation. Conclusion: These results highlight microbial–host gene interactions associated with POR. The pathogenic ITGAM-driven immune signature and the protective Porphyromonadaceae– TFF1 –propionate axis supporting epithelial integrity may enable microbiome-informed prognostic tools and therapeutic strategies for CD POR. What is already known on this topic: Post-operative recurrence in Crohn’s disease is linked to microbial dysbiosis, particularly reduced diversity and expansion of Enterobacteriaceae. However, how microbial changes translate into host molecular mechanisms driving POR remains unclear. What this study adds: This prospective multi-omic study identifies a disrupted Porphyromonadaceae–SCFA–epithelial barrier axis and the participation of neutrophil responses in patients who develop POR at surgery time. How this study might affect research, practice or policy: The findings provide mechanistic targets for microbiome-informed risk stratification and prevention of POR. They support development of microbial or metabolite-based interventions aimed at restoring epithelial barrier function after surgery.